Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma

NCT07164469 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma
Hodgkin Lymphoma

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: CD70.CAR NK Cells
DRUG: Rimiducid (AP1903)

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]